Efficacy of antidepressant medications in children and adolescents with non-obsessive–compulsive disorder anxiety disorders: a systematic assessment

Bibliography

• Bernstein GA, Shaw K. Practice parameters for the assessment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. Am Acad Child Adolesc Psychiatry 1997;36:69-84
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. American Psychiatric Association, Washington DC;
   Google Scholar
• Bernstein BE. Anxiety Disorder: Separation Anxiety and School Refusal. Available from: http://emedicine.medscape.com/article/916737-overview [Accessed 3 January 2009]
   Google Scholar
• Bowen RC, Offord DR, Boyle MH. The prevalence of overanxious disorder and separation anxiety disorder: results from the Ontario Child Health Study. J Am Acad Child Adolesc Psychiatry 1990;29:753-8
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Avenevoli S, Acharrya S, et al. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry 2002;51:81-91
   PubMed Web of Science ®Google Scholar
• Clark DB, Smith MG, Neighbors BD, et al. Anxiety disorders in adolescence: characteristics, prevalence, and comorbidities. Clin Psychol Rev 1994;14:113-37
   Web of Science ®Google Scholar
• Otto MW, Pollack MH, Maki KM, et al. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anx 2001;14:209-13
   PubMed Web of Science ®Google Scholar
• Reitman DS, Gildner JL, Holm-Larsen LH, Sylvester C. Anxiety disorder, panic disorder. Available from: http://emedicine.medscape.com/article/914490-overview [Accessed 1 February 2010]
   Google Scholar
• American Academy of Child and Adolescent Psychiatry. Panic disorder in children and adolescents. Available from: http://aacap.org/page.ww?name=Panic+Disorder+in+Children+and+Adolescents&section=Facts+for+Families [Accessed 1 February 2010]
   Google Scholar
• Greco LA, Morris TL. Factors influencing the link between social anxiety and peer acceptance: contributions of social skills and close friendships during middle childhood. Behav Ther 2005;36:197-205
   Web of Science ®Google Scholar
• Davidson JRT, Hughes DL, George LK. The epidemiology of social phobia: findings from the Duke Epidemiological Catchments Area Study. Psychol Med 1993;23:709-18
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Avenevoli S, Acharrya S, et al. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry 2002;51:81-91
   PubMed Web of Science ®Google Scholar
• Spence S, Donovan C, Brechman-Toussaint M. Social skills, social outcomes, and cognitive features of childhood social phobia. J Abnorm Child Psychol 1999;108:211-21
   Web of Science ®Google Scholar
• Bernstein BE. Anxiety Disorder, Separation Anxiety and School Refusal. Available from: http://emedicine.medscape.com/article/916737-overview [Accessed 26 February 2010]
   Google Scholar
• Kearney CA, Sims KE, Pursell CR, Tillotson CA. Separation anxiety disorder in young children: a longitudinal and family analysis. J Clin Child Adolesc Psychol 2003;32:593-8
   PubMed Web of Science ®Google Scholar
• Hersov LA. Persistent non-attendance at school. J Child Psychol Psychiatry 1960;1:30-136
   Web of Science ®Google Scholar
• Egger HL, Costello JE, Angold A. School refusal and psychiatric disorders: a community study. J Am Acad Child Adolesc Psychiatry 2003;42:789-807
   Web of Science ®Google Scholar
• Hersov LA. Refusal to go to school. J Child Psychol Psychiatry 1960;1:137-45
   Web of Science ®Google Scholar
• American Academy of Child and Adolescent Psychiatry. Children who won't go to school. Available from: http://aacap.org/page.ww?name=Children+Who+Won't+Go+to+School+(Separation+Anxiety)&section=Facts+for+Families [Accessed 25 February 2011]
   Google Scholar
• Heyne D, King NJ, Tonge BJ, Cooper H. School refusal: epidemiology and management. Paediatr Drugs 2001;3:719-32
   PubMedGoogle Scholar
• Ginsburg GS, Becker EM, Keeton CP, et al. Naturalistic follow-up of youths treated for pediatric anxiety disorders. JAMA Psychiatry 2014;71(3):310-18
   PubMed Web of Science ®Google Scholar
• Dugas M, Zarifan E, Leheuzey MF, et al. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient. Ther Drug Monitor 1980;2:307-14
   PubMed Web of Science ®Google Scholar
• Fegert JM, Kolch M, Zito JM, et al. Antidepressant use in children and adolescents in Germany. Child Adolesc Psychopharmacol 2006;16:197-206
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ, Dosreis S. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003;157:17-25
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ, De-Jong van den Berg LTW, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Mental Health 2008;2:26-34
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Public health advisory on suicidality in children and adolescents being treated with antidepressant medications. Available from: http://www.medscape.com/viewarticle/491448 [Accessed 28 December 2008]
   Google Scholar
• Schneeweiss S, Patrick AR, Solomon DH, et al. Comparative safety of antidepressants agents for children and adolescents regarding suicidal acts. Pediatrics 2010;125:876-88
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications. Available from: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html [Accessed 28 December 2008]
   Google Scholar
• Canadian Psychiatric Association Bulletin. Health Canada to examine SSRIs in children. Available from: http://ww1.cpaapc.org:8080/Publications/Archives/Bulletin/2004/april/news32En.asp [Accessed 28 December 2008]
   Google Scholar
• Adverse Drug Reactions Advisory Committee. Use of SSRI antidepressants in children and adolescents. Available from: http://www.tga.gov.au/adr/adrac_ssri.htm [Accessed 1 November 2008]
   Google Scholar
• National Institute of Mental Health. Antidepressant medications for children and adolescents: information for parents and caregivers. Available from: http://ww.mimh.nih.gov/health/topics/child-and-adolescent-mental health/antidepressant.htm [Accessed 1 November 2008]
   Google Scholar
• Owens JA, Rosewn CL, Mindell JA, Kirchner HL. Use of pharmacotherapy for insomnia in child psychiatric practice: a national survey. Sleep Med 2010;11:692-700
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescription and suicide in children and adolescents. Am J Psychiatry 2007;164:1356-63
   PubMed Web of Science ®Google Scholar
• Libby AM, Brent DA, Morrato EH, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884-91
   PubMed Web of Science ®Google Scholar
• Beidel DC, Turner SM, Sallee FR, et al. SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry 2007;46:1622-32
   PubMed Web of Science ®Google Scholar
• Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994;33:1000-6
   PubMed Web of Science ®Google Scholar
• Schwartz RH, Shipon-Blum E. "Shy" child? Don't overlook selective Mutism. Available from: http://selectivemutismcenter.org/contemp.htm [Accessed 3 January 2009]
   Google Scholar
• Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl J Med 2001;344:1279-85
   PubMed Web of Science ®Google Scholar
• Wagner KD, Berard R, Stein MB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorders. Arch Gen Psychiatry 2004;61:1153-62
   PubMed Web of Science ®Google Scholar
• Mancini C, Van Ameringen M, Oakman JM, Farvolden P. Serotoninergic agents in the treatment of social phobia in children and adolescents: a case-series. Depress Anx 1999;10:33-9
   PubMed Web of Science ®Google Scholar
• Chavira DA, Stein MB. Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. J Child Adolesc Psychopharmacol 2002;12:47-53
   PubMed Web of Science ®Google Scholar
• Schirman S, Kronenberg S, Apter A, et al. Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study. J Neural Transm 2010;117:139-45
   PubMed Web of Science ®Google Scholar
• Isolan L, Pheula G, Salum GA Jr, et al. An open-label trial of escitalopram in children and adolescents with social anxiety disorder. J Child Adolesc Psychopharmacol 2007;17:751-9
   PubMed Web of Science ®Google Scholar
• March JS, Entusah R, Rynn M, et al. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry 2007;62:1149-54
   PubMed Web of Science ®Google Scholar
• Mratkotsky C, Masek B, Biederman J, et al. Prospective open-label trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord 2008;22:88-97
   PubMed Web of Science ®Google Scholar
• Frommer EA. Treatment of childhood depression with antidepressant drugs. Br Med J 1967;3:729-32
   Google Scholar
• Robert R, Tcheung WJ, Rosemberg L, et al. Treating thermally injured children suffering from symptoms of acute stress with imipramine and fluoxetine: a randomised, double-blind study. Burns 2008;34:919-28
   PubMed Web of Science ®Google Scholar
• Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD syndrome. J Am Acad Child Adolesc Psychiatry 2007;46:811-19
   PubMed Web of Science ®Google Scholar
• Robert AS, Cueva JE, Sporn J, et al. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adol Psychopharmacol 2010;20:463-71
   PubMed Web of Science ®Google Scholar
• Stoddard FJ Jr, Luthra R, Sorrentino EA, et al. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in children. J Child Adol Psychopharmacol 2011;21:469-77
   PubMed Web of Science ®Google Scholar
• Robert R, Blakeney PE, Villareal C, et al. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder. J Am Acad Child Adolesc Psychiatry 1999;38:873-82
   PubMed Web of Science ®Google Scholar
• Birmaher B, Waterman S, Ryan N, et al. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994;33:993-9
   PubMed Web of Science ®Google Scholar
• Fairbanks JM, Pine DS, Tancer NK, et al. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 1997;7:17-29
   PubMed Web of Science ®Google Scholar
• Birmaher B, Axelson D, Monk K, et al. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42(4):415-23
   PubMed Web of Science ®Google Scholar
• Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001;158:2008-14
   PubMed Web of Science ®Google Scholar
• Walkup JT, Albano AM, Piacentini J. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:2753-276
   PubMed Web of Science ®Google Scholar
• Compton SN, Grant PJ, Chrisman AK, et al. Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 2001;40:564-71
   PubMed Web of Science ®Google Scholar
• Gunther T, Holtkamp K, Jolles J, et al. The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders. J Child Adolesc Psychopharmacol 2005;15:608-18
   PubMed Web of Science ®Google Scholar
• Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007;164:290-300
   PubMed Web of Science ®Google Scholar
• Berney T, Kolvin I, Bathe SR, et al. School phobia a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry 1981;138:110-18
   PubMed Web of Science ®Google Scholar
• Gittelman-Klein R, Klein DF, Oaks G. Controlled imipramine treatment of school phobia. Arch Gen Psychiatry 1971;25:204-7
   Web of Science ®Google Scholar
• Bernstein GA, Borchardt CM, Perwien AR, et al. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 2000;39:276-83
   PubMed Web of Science ®Google Scholar
• Bernstein GA, Garkinkel BD, Borchardt CM. Comparative studies of pharmacotherapy of school refusal. J Am Acad Child Adolesc Psychiatry 1990;29:773-81
   PubMed Web of Science ®Google Scholar
• Rabiner CJ, Klein DF. Imipramine treatment of school phobia. Compr Psychiatry 1969;10:387-90
   PubMed Web of Science ®Google Scholar
• Klein RG, Koplewicz HS, Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry 1992;31:21-7
   PubMed Web of Science ®Google Scholar
• Wong P. Selective mutism: a review of etiology, comorbidities, and treatment. Psychiatry 2010;7:23-31
   PubMedGoogle Scholar
• Hetrick SE, Purcell R, Gamer B, Parslow R. Combined pharmacotherapy and psychological therapies for posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2010(7):CD0057316
   Web of Science ®Google Scholar
• McClure EB, Adler A, Monk CS, et al. fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) 2007;191:97-105
   PubMed Web of Science ®Google Scholar
• Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2009(3):CD005170
   PubMed Web of Science ®Google Scholar
• Bailly D. Benefits and risks of using antidepressants in children and adolescents. Expert Opin Drug Saf 2008;7:9-27
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. A meta-analysis of randomized controlled trial. JAMA 2007;297:1683-96
   PubMed Web of Science ®Google Scholar
• Uthman OA, Abdulmalik J. Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis. Curr Med Res Opin 2010;26:53-9
   PubMed Web of Science ®Google Scholar
• Gentile S. Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal. J Clin Psychopharmacol 2011;5:625-32
   Web of Science ®Google Scholar